The National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH/NIAID), intends to procure fetal bovine Serum on a sole source. The solicitation number for this acquisition is NIAID-NOI-16B1795925 and the solicitation is being issued as Notice of Intent. Gemini is the only known vendor able to provide fetal bovine serum compatible with the experiments currently being conducted. This acquisition will be processed using Simplified Acquisition Procedures and is not a Small Business set aside, however, small, small disadvantage, minority, veteran owned, and HUD zone companies, etc. are encouraged to submit quotes. The North American Industry Classification System (NAICS) Code for this acquisition is 811219, which has a size standard of $19.0 million..

Line Item#/Description/Quantity:

 

1) US Origin Fetal Bovine Serum, 500ml Lot# A35F00H, Qty of 200

All responsible sources who feel they can meet these requirements shall submit their capabilities that will be considered. The government reserves the right to make a decision whether this requirement is available for competition. The Period of Performance will be 12 months from the date of award. Offers must be submitted no later than 4:00 p.m. Eastern Time (ET), July 28 2016. Delivery address through the U.S. Postal Service, NIH/NIAID/AMOB, 5601 Fishers Lane, RM 3a64 Rockville, MD 20852. Electronic and fax quotations are not accepted. Requests for information concerning this requirement are to be addressed to Daniel Herdman at 240-669-5102 or [email protected] referencing the solicitation number. The vendor is responsible to confirm receipt of all quotations, emails and/or questions by the closing date of this announcement. Collect calls will not be accepted.

Bid Protests Not Available